Skip to content

Continuous digital monitoring of glucose concentration (CGM) depending of lifestyle in healthy adults and evaluation of the new CGM health metrics

Continuous digital monitoring of glucose concentration (CGM) depending of lifestyle in healthy adults and evaluation of the new CGM health metrics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032597
Enrollment
6
Registered
2023-10-05
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11 I10-I15

Interventions

Group 1: Single arm, intervention group without control Wearing a CGM sensor for 14 days Wear a Holter blood pressure monitor for 14 days Pre- and post-survey about the level of knowledge and self-as

Sponsors

Institut für Klinische Pharmazie und Pharmakotherapie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy pharmacy students in the 7th semester of pharmacy at the HHU Düsseldorf who voluntarily gave their consent to participate

Exclusion criteria

Exclusion criteria: Lack of informed consent to participate in the study Lack of consent to data protection Diagnosis of diabetes mellitus type 1 or 2

Design outcomes

Primary

MeasureTime frame
CGM metrics: time in target range [70-180 mg/dL], number of hypoglycemias, number of hyperglycemias, glucose exposure (area under the curve), glucose variability long-term blood pressure monitor: data collection

Secondary

MeasureTime frame
Knowledge development on the topic of “digital health” Satisfaction & experience with the CGM system or long-term blood pressure monitor, quality of life while wearing the systems

Countries

Germany

Contacts

Public ContactFlorian Kinny

Institut für Klinische Pharmazie und Pharmakotherapie

Florian.Kinny@hhu.de+49 211 81-13840

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026